Professional
Added to YB: 2024-11-26
Pitch date: 2024-11-24
BAYN.DE [neutral]
Bayer Aktiengesellschaft
+83.51%
current return
Author Info
The Superinvestors of Augustusville runs a small family office and shares pitches for their investments. Sign up for their newsletter.
Company Info
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments.
Market Cap
EUR 28.5B
Pitch Price
EUR 19.85
Price Target
N/A
Dividend
0.38%
EV/EBITDA
7.40
P/E
-144.19
EV/Sales
1.33
Sector
Pharmaceuticals
Category
turnaround
Bottom Fishing in Sick Man's Land - Bayer Aktiengesellschaft
BAYN.DE: German pharma giant post-Monsanto acquisition struggles with debt, litigation, cyclicality. New CEO Anderson leading turnaround: efficiency programs, employee cuts, dividend slash. Generating cash, BBB rating. 6x EBITDA valuation attractive. History of comebacks and spin-offs (Lanxess, Covestro) offers hope.
Read full article (2 min)